Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors

  • Ligaya M. Simpkins
  • , Scott Bolton
  • , Zulan Pi
  • , James C. Sutton
  • , Chet Kwon
  • , Guohua Zhao
  • , David R. Magnin
  • , David J. Augeri
  • , Timur Gungor
  • , David P. Rotella
  • , Zhong Sun
  • , Yajun Liu
  • , William S. Slusarchyk
  • , Jovita Marcinkeviciene
  • , James G. Robertson
  • , Aiying Wang
  • , Jeffrey A. Robl
  • , Karnail S. Atwal
  • , Robert L. Zahler
  • , Rex A. Parker
  • Mark S. Kirby, Lawrence G. Hamann

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

The synthesis and structure-activity relationships of novel dipeptidyl peptidase IV inhibitors replacing the classical cyanopyrrolidine P1 group with other small nitrogen heterocycles are described. A unique potency enhancement was achieved with β-branched natural and unnatural amino acids, particularly adamantylglycines, linked to a (2S,3R)-2,3-methanopyrrolidine based scaffold.

Original languageEnglish
Pages (from-to)6476-6480
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume17
Issue number23
DOIs
StatePublished - 1 Dec 2007

Keywords

  • DPP4
  • Diabetes
  • GLP-1
  • Non-nitrile
  • Serine protease

Fingerprint

Dive into the research topics of 'Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors'. Together they form a unique fingerprint.

Cite this